Clinical Trials in New York

Showing 5001-5020 of 22,668 trials

A Double-blind Study to Evaluate the Safety of Glutamic Acid Decarboxylase Gene Transfer in Parkinson's Participants

NCT05603312

The objective of this clinical trial was to evaluate the safety and tolerability of adeno-associated virus (AAV)-mediated delivery of glutamic acid decarboxylase (GAD) gene transfer into the subthalamic nuclei (STN) of participants with Parkinson's Disease.

Parkinson's Disease

MeiraGTx, LLC14 participantsStarted Oct 2022

New Haven, Connecticut, United States • West Bloomfield, Michigan, United States • New York, New York, United States +3 more locations

Active Not RecruitingPhase 3< 1 mile

A Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy

NCT05444257

The purpose of this study is to evaluate the long-term safety, tolerability, and efficacy of VX-121/tezacaftor/deutivacaftor (VX-121/TEZ/D-IVA) in participants with cystic fibrosis.

Cystic Fibrosis

Vertex Pharmaceuticals Incorporated822 participantsStarted Nov 2022

Birmingham, Alabama, United States • Tucson, Arizona, United States • Little Rock, Arkansas, United States +192 more locations

A Double-blind Study to Evaluate the Safety of Glutamic Acid Decarboxylase Gene Transfer in Parkinson's Participants

A Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy

Find Trials by Condition in New York

CREST-2 Long-term Observational Extension Study

A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Eosinophilic Asthma

Tapinarof for the Treatment of Atopic Dermatitis in Children and Adults

Tier - Palliative Care For Patients With Advanced Heart Failure or Cancer

Expanded Access Program for Revumenib

A 12-week Study to Evaluate the Efficacy and Safety of HP-5000 in Subjects With Osteoarthritis Pain of the Knee

A Study of Danicopan in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Cardiovascular Function and Response to Stimulation Within the First Year After Spinal Cord Injury

Implementing Mobile Technology for Unhealthy Alcohol Use

Investigation of Effects of Delayed Feedback on Non-motor Symptoms in Individuals With Parkinson's Disease

GV1001 Subcutaneous(SC) for the Treatment of Mild to Moderate Alzheimer's Disease (AD)

Efficacy, Safety, Tolerability, and Pharmacokinetics of NBI-827104 in Pediatric Subjects With Epileptic Encephalopathy With Continuous Spike-and-Wave During Sleep

Tau PET/CT Imaging in the Mismatch Prospective Cohort Study (MPC-TAU)

A Study Evaluating B Cell Levels In Infants Potentially Exposed To Ocrelizumab During Pregnancy

Cognitive Behavioural Therapy to Optimize Post-Operative Recovery Trial

Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment

The PLATFORM Study: Prospective LongitudinAl Trial of FFRct: Outcome and Resource IMpacts)

Gene Therapy for Pyruvate Kinase Deficiency (PKD)